Dual Affinity Polypeptide Purification Process

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional affinity chromatography is costly and limited by the need for multiple column reuse, leading to extended production processes and capacity loss, with high costs and risks of contamination, and requires complex regeneration procedures and harsh cleaning protocols, which are time-consuming and costly.

Innovation Solution

A dual affinity polypeptide process that uses a semi-generic dual affinity polypeptide with different binding affinities for the target biomolecule and the capturing ligand, allowing for non-covalent binding to a generic affinity matrix, enabling efficient recovery of the target biomolecule by elution while leaving the dual affinity polypeptide attached to the ligand, thus preventing leakage and simplifying the purification process.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If conventional affinity chromatography uses immobilized ligands on solid phase matrices with reversible binding, then target molecules can be recovered by dissociation at eluting conditions, but the dissociation constant between ligand and target protein is limited to about 10^-5 M, restricting binding strength

Engineering Contradiction:
Improvebinding strengthVSAvoidrecovery efficiency
Core Design Contradiction:
StrengthVSReliability

Solution Approach 1:

The invention divides the binding system into three components: the solid phase matrix, the ligand, and the dual affinity polypeptide. The dual affinity polypeptide acts as an intermediary that segments the direct ligand-target interaction into two separate interactions: ligand-DAP and DAP-target binding. This segmentation allows each interaction to be optimized independently, with the ligand-DAP bond being stronger than traditional ligand-target bonds.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The dual affinity polypeptide serves as an intermediary molecule between the ligand and the target biomolecule. It contains two different binding sites: one that binds to the ligand with high affinity (lower Kd) and another that binds to the target biomolecule. This intermediary approach enables stronger overall binding while maintaining reversible elution capabilities.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If affinity columns are reused multiple times to reduce costs, then manufacturing cost decreases, but production process time extends and capacity loss increases

Engineering Contradiction:
Improvemanufacturing costVSAvoidproduction efficiency
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The invention employs a disposable solid phase matrix containing the ligand that is used for a single purification cycle and then discarded. This eliminates the need for time-consuming regeneration and cleaning protocols required for column reuse, thereby maintaining high productivity while reducing costs associated with column maintenance and validation.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Ease of manufacture

If affinity columns are reused requiring regeneration procedures, then cost per batch decreases, but complex regeneration and harsh cleaning protocols increase time consumption and contamination risk

Engineering Contradiction:
Improvecost per batchVSAvoidtime for regeneration
Core Design Contradiction:
Ease of manufactureVSLoss of time

Solution Approach 1:

The solid phase matrix is designed as a single-use component that eliminates regeneration requirements. The low cost of the disposable matrix allows the system to forgo expensive and time-consuming regeneration protocols, thereby reducing both time loss and contamination risk while maintaining cost-effectiveness.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

Instead of reusing the expensive ligand-bound matrix and regenerating it, the invention inverts the approach by using a cheap disposable matrix and recovering the valuable target biomolecule in high purity. The value is placed on the purified product rather than the reusable column.

Inventive Principle:
Principle #13The other way round (Inversion)

4Ease of operation

If conventional affinity chromatography uses ligands covalently attached to matrices, then the system is ready to use immediately, but the ligand-target dissociation requires harsh conditions that may damage biomolecules

Engineering Contradiction:
Improvereadiness to useVSAvoidbiomolecule damage
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The dual affinity polypeptide acts as a protective intermediary that allows mild elution conditions. The ligand binds to the DAP with high affinity, and the DAP binds to the target biomolecule, creating a buffered interaction system. This intermediary structure enables elution under gentle conditions that preserve biomolecule integrity while still achieving effective separation.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly reduces costs, simplifies downstream processing, and eliminates the need for complex regeneration and cleaning protocols, allowing for more flexible elution conditions and reducing the risk of contamination, while maintaining high purity and efficiency in target biomolecule recovery.

Implementation Method 1

A dual affinity polypeptide process that uses a semi-generic dual affinity polypeptide with different binding affinities for the target biomolecule and the capturing ligand, allowing for non-covalent binding to a generic affinity matrix

Methodology Applied
Scientific EffectNon-covalent binding: Adsorption

Implementation Method 2

contacting (i) a target biomolecule, (ii) a dual affinity polypeptide, and (iii) a solid support comprising a catching ligand

Methodology Applied
Scientific EffectAffinity binding: Adsorption

Data Source

PatentEP2220107B1Dual affinity polypeptides for purification
Publication Date: 2016.11.02 CHRETO APS
  • EP2220107B1 patent drawing
  • EP2220107B1 patent drawing
  • EP2220107B1 patent drawing

AI summary

The present invention relates to a process for purification of a target biomolecule, comprising the steps: (a) contacting (i) a target biomolecule, (ii) a dual affinity polypeptide, and (iii) a solid support comprising a catching ligand, wherein the ratio between the equilibrium dissociation constants of the dual affinity polypeptide, [KD, t / KD, s ], is at least 10° at standard conditions; and (b) recovering the target biomolecule by elution.